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Summary
Objective: To assess the proportion of patients re-registered after default, failure or successful treatment, completion and
evaluate their treatment outcome.
Setting:  Tuberculosis patients diagnosed were registered for treatment under DOTS in rural area, South India. Patients re-
registered during 1999-2004 identified from the TB register were considered for analysis.
Results:  Among 273 Category-I patients ‘defaulted’ 23% and among 112 ‘failure’ cases 68% were re-registered. After
‘successful treatment completion’ of 1796 cases 6.5% were re-registered as relapse.  Corresponding figures for Category II
were 20% of 281 defaulters; 23% of 60 failures; 12.9% of 302 ‘successful treatment completion’ patients. Among patients
re-registered as ‘default’, subsequent default was also high (57% vs 37%).  Failure in Category II treatment was similar
among patients who were re-registered for Category II and initially registered in it for treatment.  Median delay for re-
registration was >200 days for ‘defaulters’ and 18 days for ‘failures’.
Conclusion: Our findings emphasise the need for continuing motivation and prompt defaulter retrieval action to
reduce default at all stages of treatment. ‘Defaulters’ need to be contacted so that they can be started on treatment
without delay. Patients declared as ‘successful treatment completion’ should be encouraged to report if chest
symptoms recur.
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INTRODUCTION
The Revised National Tuberculosis
Control Programme (RNTCP) based on the World
Health Organization’s Directly Observed
Treatment-Short Course (DOTS) strategy was
launched by Government of India in a phased
manner since 1993. The progress of patients
started on treatment is monitored and treatment
outcome given as per international definitions1.
Patients who are declared as ‘failure’ or relapsed
after being declared as ‘cure’ or ‘treatment
completed’ and ‘default’ after receiving one month
or more of treatment will be re-registered for
treatment under Category II. Not much
information is available on the proportion of
patients re-registered and their treatment
outcomes according to type at re-registration. This
paper presents data on the above issues.
MATERIAL  AND  METHODS
The DOTS programme was implemented
in 1999 in the study area of Tiruvallur district, Tamil
Nadu covering a population of 580,000. Patients
diagnosed with tuberculosis in this area were
registered for treatment under DOTS. All patients
registered from May 1999 to 2004 were considered
for the analyses. A patient was considered as re-
registered for treatment if he/she was already
registered previously for treatment in the same
Tuberculosis Unit (TU).
Data collection
The details of the patients registered for
treatment under DOTS were collected from the
Tuberculosis (TB) register maintained in the TU.  A
patient started on treatment is assigned a unique TB
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number along with the year of registration. When a
patient is re-registered, a new TB number will be
allotted at the time of re-registration.
Statistical analyses
The data from TB register after scrutiny
were computerized, verified keying in twice, edited
and corrected for discrepancy and missing
information. The Chi-square test was used to test
difference in proportions. The level of statistical
significance was defined as P < 0.05.
RESULTS
From May 1999 through December 2004,
2608 patients were started on Category I treatment,
803 on Category II, 1844 on Category III and 111
on non-DOTS (non-DOTS excluded for analysis).
Of 2287 new smear positive patients registered in
Category I, 1796 (79%) had ‘successful treatment
completion’, 273 (12%) ‘Defaulted’, 99 (4%)
‘Expired’, and 112 (5%)  ‘Failed’ and 7 (<1%) were
‘transferred out’. Corresponding figures for 699
smear positive Category II patients were 302 (43%),
281 (40%), 47 (7%), 60 (9%) and 9 (1%), and for
2165 new smear negative and extra pulmonary
patients (including 321 smear negative and extra
pulmonary TB patients treated with Category I) were
1814 (84%), 231 (11%), 89 (4%), 27 (1%) and 4
(<1%) respectively. A total of 444 (403 smear-
positive and 41 smear-negative) patients were re-
registered during 1999-2004, including 57 patients
who were re-registered twice and eight 3-times and
one 4-times in the same TU. Of the patients registered
between 1999 and 2004, 273 patients were re-
registered of whom 248 (91%) were re-registered
within 2-years (Table 1).
Admission Re-Registration 
Year         No. 2000 2001 2002 2003 2004 Total 
1999        407 32 14   5   1   0           52 
2000        970 10 55 31 11   3         110 
2001      1046 - 25 55 26   5         111 
2002      1097 - - 18 62 19           99 
2003        947 - - - 12 51           63 
2004        899 - - - -   9             9 
 
Treatment outcome* 
Default Failure 
Treatment Success   
 
Started treatment Total Re-registered 
(%) 
Total Re-registered 
(%) 
Total Re-registered 
(%) 
Category-I 
Smear Positive 
273 64(23) 112 76(68) 1796 117(6.5) 
Category-II 
Smear Positive 
281 56(20) 60 14(23) 302 39(12.9) 
New  Smear 
Negative and 
Extra Pulmonary 
231 16(7) 27 21(78) 1844 25(1.4) 
* 16 re-registered cases excluded (1 ‘transfer out’, 8 non-DOTS and 7 Category II smear negative) 
Table 1: Year of initial registration and re-registration of patients treated under DOTS
Table 2:  Proportion of patients re-registered according to Category of patients started on treatment
and its outcome (May 1999 –Dec 2004).
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The proportion re-registered according to
initial category and treatment outcome is given in
Table 2. From Category I smear positive patients,
64 (23%) of 273 ‘defaulted’, 76 (68%) of 112
‘failures’ and 117 (6.5%) of 1796 ‘treatment success’
patients were re-registered for treatment. The
corresponding figures for Category II patients were
20%, 23% and 12.9% and for new smear negative
and extra pulmonary cases 7%, 78% and 1.3%,
respectively.  We have excluded 1 patient from the
‘transfer out’, 8 started on non-DOTS treatment and
7 Category II smear negative at the time of re-
registration.
The median interval between declaring the
treatment outcome and re-start of treatment was 228
days for 109 ‘default’ and 18 days for 105 ‘failure’
and  212 days for 163 ‘relapse’ patients (Table 3).
Of the 57 patients who were re-registered
for the second time, 23 were defaulters, 16 relapses,
10 failures, 4 were re-registered as ‘new’ cases and
4 as others.
Category I  
Smear positive. 
Category II 
Smear  positive 
New  
Smear negative and 
Extra Pulmonary 
Total 
(No. in first time 
re-registration) 
Outcome 
No. Median 
days 
No. Median 
days 
No. Median 
days 
No. Median 
days 
Default 64 228 56 224 16 438 136 
(104) 
234   
(230) 
Failure 76 18 14 72 21 12 111 
(104) 
19  
(18) 
Relapse 117 219 39 198 25 192 181 
(161) 
210 
(212) 
 
Treatment outcome Type 
Total Treatment 
Success 
(%) 
Default 
 (%) 
Died  
(%) 
Failure 
(%) 
Others 
(%) 
Default 
 Re-Registered 
 Initially Category II* 
 
117 
215 
 
31(26) 
98(46) 
 
67(57) 
79(37) 
 
11(9) 
17(8) 
 
7(6) 
16(7) 
 
1(1) 
5(2) 
Failure 
Re-Registered 
Initially Category II* 
 
104 
34 
 
37(36) 
15(44) 
 
44(42) 
12(35) 
 
6(6) 
3(9) 
 
17(16) 
3(9) 
 
- 
1(3) 
Relapse 
Re-Registered 
Initially Category II* 
 
131 
95 
 
64(49) 
55(58) 
 
49(37) 
29(31) 
 
6(5) 
4(4) 
 
11(8) 
6(6) 
 
1(1) 
1(1) 
Total  
Re-Registered 
Initially Category II* 
 
352 
344 
 
132(38) 
168(49) 
 
160(45) 
120(35) 
 
23(7) 
24(7) 
 
35(10) 
25(7) 
 
2(1) 
7(2) 
* includes cases registered at the commencement of DOTS,  previously treated by private practitioners  for one month and above  
   and treated in other TUs 
 
Table 3: Median interval between declaration of treatment outcome and re-start of treatment
Table 4: Treatment outcome according to type at the time of re-registration and initially registered as
Category II Smear positive cases
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The ‘type of disease’ at the time of re-
registration was correctly classified based on initial
treatment outcome for 351 of 444 (79%): ‘treatment
after default’ 87% (128/147), ‘failure’ 82% (92/112)
and   ‘relapse’ 71% (131/184) of patients.
Table 4 describes the treatment outcome of
699 smear positive patients (after excluding 3 patients
‘transfer out’) of the total 803 Category II patients
registered during the study period of which 352 were
re-registered and the remaining 344 were initially
registered. The successful treatment outcome was
significantly lower {132 of 352 (38%) vs 168 of
344 (49%), P< 0.01)} among re-registered patients.
This was mainly due to the significantly higher
default, particularly among patients typed as
‘treatment after default’ (67 of 117 vs 79 of 215,
p<0.01). However, the failure was similar in the two
groups.
DISCUSSION
The overall treatment outcome among
Category II patients reported here is similar to another
study2 on re-treatment outcome of smear positive
patients. Hence we analysed the outcome of patients
initially registered as Category II and re-registered
to Category II.
The main findings of the present study were
that 68% of the failures and 23% of the defaulters
from Category I treatment were only re-registered.
This brings forth the need to motivate patients who
fail in Category I regimen to restart treatment and
prompt default retrieval actions to reduce ‘default’.
The proportion was much less among Category II
failures and defaulters. The RNTCP recommendation
to refer failures of Category II to higher institutions
for further management could explain the lower re-
registration of failure to Category II.  We were unable
to estimate the proportion of patients re-registered
among those relapsed since we do not have the actual
number relapsed among successful treatment
completion.  However, the proportion of relapse
cases registered was lower than the relapse rate of
12% reported from an earlier study from the same
area3 where patients with treatment success were
followed-up. This stresses the point that patients
who have successfully completed treatment need
to be advised to report if they develop chest
symptoms. The high proportion of defaulters not
returning for treatment is of concern for TB
control since they may continue to spread the
disease and calls for attempts to retrieve these
patients and put them on treatment. This would
also help to reduce the delay in restarting treatment
for these patients.
The higher default rate among the re-
registered patients under type ‘default’ could be
because they continue to default suggesting the need
for more intense and continuing motivation efforts
for these patients. No significant difference in default
was observed for those declared ‘failure’ between
the two groups.
RNTCP as a policy emphasizes on the new
smear positive patients and their treatment outcome.
Our findings suggest that it is essential to monitor
re-treatment patients with same vigour to reduce
default and improve their treatment outcome.
A limitation of the study was that the
defaulted patients were not visited to find out reason
and no attempt was made to visit the patients who
didn’t turn-up for re-starting treatment. Another
limitation is that the analysis is based on self-reporting
patients who were re-registered in the same TU, but
did not cover patients who would have reported to
any other TU or to private sector.
In conclusion, the study demonstrated
that higher default occurred among re-
registered patients resulting in low successful
treatment outcome. The fact that only 23%
of patients who had defaulted were re-
registered and the higher default (57%)
among patients re-registered emphasizes the
need to motivate them for continuing the
treatment.  Studies are required to find out
reasons for those who did not turn up for re-
treatment and evolve methods to ensure their
return to treatment.
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Sixty-First National Conference on Tuberculosis and Chest Diseases
The Sixty-First National Conference on Tuberculosis and Chest
Diseases will be held at RNT Medical College, Udaipur (Rajasthan) from
23rd to 25th February, 2006.  Registration-cum-brochure forms can be obtained
from the Secretary General, Tuberculosis Association of India, 3-Red Cross
Road, New Delhi-110 001.
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